Don't know if you guys saw this a couple days ago,
Post# of 30028
announces the appointment of Mr. Heng Fai Chan to the
Company's Board of Directors. Concurrently, Heng Fai Enterprises Pte Ltd., controlled by
Mr. Chan, made an investment into Vivacitas Oncology through the purchase of common
stock
"Vivacitas represents a tremendous investment opportunity in the field of oncologic drug
development as the pipeline assets have progressed to a relatively late stage and are
differentiated from other camptothecins in their improved formulations and reduced side
effects," said Mr. Chan
My immediate focus is to help the
Company with its capital raising efforts and strategic transactions as we bring new
treatments forward for patients."